The dichotomous and incomplete adaptive immunity in COVID-19 patients with different disease severity
Title: | The dichotomous and incomplete adaptive immunity in COVID-19 patients with different disease severity |
---|---|
Authors: | Leiqiong Gao, Jing Zhou, Sen Yang, Lisha Wang, Xiangyu Chen, Yang Yang, Ren Li, Zhiwei Pan, Jing Zhao, Zhirong Li, Qizhao Huang, Jianfang Tang, Li Hu, Pinghuang Liu, Guozhong Zhang, Yaokai Chen, Lilin Ye |
Source: | Signal Transduction and Targeted Therapy, Vol 6, Iss 1, Pp 1-10 (2021) |
Publisher Information: | Nature Publishing Group, 2021. |
Publication Year: | 2021 |
Collection: | LCC:Medicine LCC:Biology (General) |
Subject Terms: | Medicine, Biology (General), QH301-705.5 |
More Details: | Abstract The adaptive immunity that protects patients from coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is not well characterized. In particular, the asymptomatic patients have been found to induce weak and transient SARS-CoV-2 antibody responses, but the underlying mechanisms remain unknown; meanwhile, the protective immunity that guide the recovery of these asymptomatic patients is elusive. Here, we characterized SARS-CoV-2-specific B-cell and T-cell responses in 10 asymptomatic patients and 64 patients with other disease severity (mild, n = 10, moderate, n = 32, severe, n = 12) and found that asymptomatic or mild symptomatic patients failed to mount virus-specific germinal center (GC) B cell responses that result in robust and prolonged humoral immunity, assessed by GC response indicators including follicular helper T (TFH) cell and memory B cell responses as well as serum CXCL13 levels. Alternatively, these patients mounted potent virus-specific TH1 and CD8+ T cell responses. In sharp contrast, patients of moderate or severe disease induced vigorous virus-specific GC B cell responses and associated TFH responses; however, the virus-specific TH1 and CD8+ T cells were minimally induced in these patients. These results, therefore, uncovered the protective immunity in asymptomatic patients and also revealed the strikingly dichotomous and incomplete humoral and cellular immune responses in COVID-19 patients with different disease severity, providing important insights into rational design of effective COVID-19 vaccines. |
Document Type: | article |
File Description: | electronic resource |
Language: | English |
ISSN: | 2059-3635 |
Relation: | https://doaj.org/toc/2059-3635 |
DOI: | 10.1038/s41392-021-00525-3 |
Access URL: | https://doaj.org/article/2bcca2cbe28a4ebeb831552c3efb9f24 |
Accession Number: | edsdoj.2bcca2cbe28a4ebeb831552c3efb9f24 |
Database: | Directory of Open Access Journals |
FullText | Text: Availability: 0 CustomLinks: – Url: https://resolver.ebsco.com/c/xy5jbn/result?sid=EBSCO:edsdoj&genre=article&issn=20593635&ISBN=&volume=6&issue=1&date=20210301&spage=1&pages=1-10&title=Signal Transduction and Targeted Therapy&atitle=The%20dichotomous%20and%20incomplete%20adaptive%20immunity%20in%20COVID-19%20patients%20with%20different%20disease%20severity&aulast=Leiqiong%20Gao&id=DOI:10.1038/s41392-021-00525-3 Name: Full Text Finder (for New FTF UI) (s8985755) Category: fullText Text: Find It @ SCU Libraries MouseOverText: Find It @ SCU Libraries – Url: https://doaj.org/article/2bcca2cbe28a4ebeb831552c3efb9f24 Name: EDS - DOAJ (s8985755) Category: fullText Text: View record from DOAJ MouseOverText: View record from DOAJ |
---|---|
Header | DbId: edsdoj DbLabel: Directory of Open Access Journals An: edsdoj.2bcca2cbe28a4ebeb831552c3efb9f24 RelevancyScore: 944 AccessLevel: 3 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 943.972900390625 |
IllustrationInfo | |
Items | – Name: Title Label: Title Group: Ti Data: The dichotomous and incomplete adaptive immunity in COVID-19 patients with different disease severity – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Leiqiong+Gao%22">Leiqiong Gao</searchLink><br /><searchLink fieldCode="AR" term="%22Jing+Zhou%22">Jing Zhou</searchLink><br /><searchLink fieldCode="AR" term="%22Sen+Yang%22">Sen Yang</searchLink><br /><searchLink fieldCode="AR" term="%22Lisha+Wang%22">Lisha Wang</searchLink><br /><searchLink fieldCode="AR" term="%22Xiangyu+Chen%22">Xiangyu Chen</searchLink><br /><searchLink fieldCode="AR" term="%22Yang+Yang%22">Yang Yang</searchLink><br /><searchLink fieldCode="AR" term="%22Ren+Li%22">Ren Li</searchLink><br /><searchLink fieldCode="AR" term="%22Zhiwei+Pan%22">Zhiwei Pan</searchLink><br /><searchLink fieldCode="AR" term="%22Jing+Zhao%22">Jing Zhao</searchLink><br /><searchLink fieldCode="AR" term="%22Zhirong+Li%22">Zhirong Li</searchLink><br /><searchLink fieldCode="AR" term="%22Qizhao+Huang%22">Qizhao Huang</searchLink><br /><searchLink fieldCode="AR" term="%22Jianfang+Tang%22">Jianfang Tang</searchLink><br /><searchLink fieldCode="AR" term="%22Li+Hu%22">Li Hu</searchLink><br /><searchLink fieldCode="AR" term="%22Pinghuang+Liu%22">Pinghuang Liu</searchLink><br /><searchLink fieldCode="AR" term="%22Guozhong+Zhang%22">Guozhong Zhang</searchLink><br /><searchLink fieldCode="AR" term="%22Yaokai+Chen%22">Yaokai Chen</searchLink><br /><searchLink fieldCode="AR" term="%22Lilin+Ye%22">Lilin Ye</searchLink> – Name: TitleSource Label: Source Group: Src Data: Signal Transduction and Targeted Therapy, Vol 6, Iss 1, Pp 1-10 (2021) – Name: Publisher Label: Publisher Information Group: PubInfo Data: Nature Publishing Group, 2021. – Name: DatePubCY Label: Publication Year Group: Date Data: 2021 – Name: Subset Label: Collection Group: HoldingsInfo Data: LCC:Medicine<br />LCC:Biology (General) – Name: Subject Label: Subject Terms Group: Su Data: <searchLink fieldCode="DE" term="%22Medicine%22">Medicine</searchLink><br /><searchLink fieldCode="DE" term="%22Biology+%28General%29%22">Biology (General)</searchLink><br /><searchLink fieldCode="DE" term="%22QH301-705%2E5%22">QH301-705.5</searchLink> – Name: Abstract Label: Description Group: Ab Data: Abstract The adaptive immunity that protects patients from coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is not well characterized. In particular, the asymptomatic patients have been found to induce weak and transient SARS-CoV-2 antibody responses, but the underlying mechanisms remain unknown; meanwhile, the protective immunity that guide the recovery of these asymptomatic patients is elusive. Here, we characterized SARS-CoV-2-specific B-cell and T-cell responses in 10 asymptomatic patients and 64 patients with other disease severity (mild, n = 10, moderate, n = 32, severe, n = 12) and found that asymptomatic or mild symptomatic patients failed to mount virus-specific germinal center (GC) B cell responses that result in robust and prolonged humoral immunity, assessed by GC response indicators including follicular helper T (TFH) cell and memory B cell responses as well as serum CXCL13 levels. Alternatively, these patients mounted potent virus-specific TH1 and CD8+ T cell responses. In sharp contrast, patients of moderate or severe disease induced vigorous virus-specific GC B cell responses and associated TFH responses; however, the virus-specific TH1 and CD8+ T cells were minimally induced in these patients. These results, therefore, uncovered the protective immunity in asymptomatic patients and also revealed the strikingly dichotomous and incomplete humoral and cellular immune responses in COVID-19 patients with different disease severity, providing important insights into rational design of effective COVID-19 vaccines. – Name: TypeDocument Label: Document Type Group: TypDoc Data: article – Name: Format Label: File Description Group: SrcInfo Data: electronic resource – Name: Language Label: Language Group: Lang Data: English – Name: ISSN Label: ISSN Group: ISSN Data: 2059-3635 – Name: NoteTitleSource Label: Relation Group: SrcInfo Data: https://doaj.org/toc/2059-3635 – Name: DOI Label: DOI Group: ID Data: 10.1038/s41392-021-00525-3 – Name: URL Label: Access URL Group: URL Data: <link linkTarget="URL" linkTerm="https://doaj.org/article/2bcca2cbe28a4ebeb831552c3efb9f24" linkWindow="_blank">https://doaj.org/article/2bcca2cbe28a4ebeb831552c3efb9f24</link> – Name: AN Label: Accession Number Group: ID Data: edsdoj.2bcca2cbe28a4ebeb831552c3efb9f24 |
PLink | https://login.libproxy.scu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.2bcca2cbe28a4ebeb831552c3efb9f24 |
RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41392-021-00525-3 Languages: – Text: English PhysicalDescription: Pagination: PageCount: 10 StartPage: 1 Subjects: – SubjectFull: Medicine Type: general – SubjectFull: Biology (General) Type: general – SubjectFull: QH301-705.5 Type: general Titles: – TitleFull: The dichotomous and incomplete adaptive immunity in COVID-19 patients with different disease severity Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Leiqiong Gao – PersonEntity: Name: NameFull: Jing Zhou – PersonEntity: Name: NameFull: Sen Yang – PersonEntity: Name: NameFull: Lisha Wang – PersonEntity: Name: NameFull: Xiangyu Chen – PersonEntity: Name: NameFull: Yang Yang – PersonEntity: Name: NameFull: Ren Li – PersonEntity: Name: NameFull: Zhiwei Pan – PersonEntity: Name: NameFull: Jing Zhao – PersonEntity: Name: NameFull: Zhirong Li – PersonEntity: Name: NameFull: Qizhao Huang – PersonEntity: Name: NameFull: Jianfang Tang – PersonEntity: Name: NameFull: Li Hu – PersonEntity: Name: NameFull: Pinghuang Liu – PersonEntity: Name: NameFull: Guozhong Zhang – PersonEntity: Name: NameFull: Yaokai Chen – PersonEntity: Name: NameFull: Lilin Ye IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Type: published Y: 2021 Identifiers: – Type: issn-print Value: 20593635 Numbering: – Type: volume Value: 6 – Type: issue Value: 1 Titles: – TitleFull: Signal Transduction and Targeted Therapy Type: main |
ResultId | 1 |